Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Common Entry Submission Errors

Common Entry Submission Errors

                        Human Drug Common Entry Errors
          CBER Common Entry Errors
          Medical Device Common Entry Errors Home
          For Industry
          Import Program – Food and Drug Administration (FDA)
          FDA Import Process
          Entry Submission
          Common Entry Submission Errors
          CBER Common Entry ErrorsCommon Entry Submission Errors CBER Common Entry Errors
  
  	
    Share
    Post
    Linkedin

    Email
    Print**Introduction**

The Center for Biologics Evaluation and Research (CBER) regulates the following:

Biological and related products including blood, vaccines, allergenics, tissues, and cellular and gene therapies. Biologics, in contrast to drugs that are chemically synthesized, are derived from living sources (such as humans, animals, and microorganisms), are not easily identified or characterized, and many are manufactured using biotechnology.
	Certain medical devices involved in the collection, processing, testing, screening, manufacture and administration of licensed blood, blood components, and tissue and cellular products
	HIV test kits used to screen donor blood, blood components, tissue and cellular products (HCT/Ps), and products used to diagnose, treat, and monitor persons with HIV and AIDS.To expedite entry screening of CBER-regulated products by the Predictive Risk-based Evaluation for Dynamic Import Compliance Targeting (PREDICT) system, it is important that importers and entry filers  provide accurate product codes, all relevant affirmations of compliance (AofC), and accurate identifiers for firms, in addition to the general entry data.

When complete and accurate entry data is supplied electronically, it can be used by the PREDICT system to “look-up” the information in the FDA’s databases, validate the information, and issue a system “May Proceed” if the line is not held due to any other screening criteria.

When the entry data provided is not complete and/or accurate, the “look-up” will fail and the entry line may be subject to delays in processing.

Details on applicable product codes and affirmations of compliance are included in the “Additional Information” section at the bottom of this page.

The following chart shows the most common look-up errors for CBER-regulated products during Fiscal Year 2023 (10/1/2022 to 9/30/2023).

FY 23 Common Import Biologics Entry Errors Chart
When the entry data provided is not complete and/or accurate, the entry line may be subject to delays in processing.  The table below provides additional information regarding these common errors to help you provide accurate and complete information to the FDA.

Back to top

**Common Biological Look-up Errors that Result in a Failed Look-up**

Error
			Description
			Additional InformationNo AofCs provided (Intended Use Code UNK)
			No Affirmations of Compliance (AofC) were provided for the entry and the intended use code was provided as (UNK).

			Submitting UNK as the Intended Use Code will subject the entry to manual review, which will cause delays.  It might also make it difficult to identify which AofCs are mandatory and which are optional in the ACE FDA Supplemental Guide.

			If the product is FDA-regulated, supply the required AofC information and the appropriate intended use code.  If the product is not FDA-regulated, and does not require declaration to the FDA, disclaim future entries.
			For more information see Affirmations of Compliance and the FDA Supplemental Guide.No AofCs provided
			No Affirmations of Compliance (AofC) were provided for this entry.

			If the product is FDA-regulated supply the required AofC information. If the product is not FDA-regulated, and does not require declaration to the FDA, disclaim future entries.
			For more information see Affirmations of Compliance.AofCs insufficient for biologic products lookup
			The product was declared as a biologic product (Industry code 57), however, the Affirmations of Compliance (AofC) provided were insufficient to perform the lookup for biologic products.

			Verify the product code and/or AofC code or qualifier.
			For more information see Importing CBER regulated products into the United StatesSTN not found or not valid
			Submission Tracking Number (STN) transmitted could not be found in the FDA's biologic products database, is not valid, or was declared in an improper format.

			Verify correct AofC code and corresponding qualifier.
			The qualifier for this affirmation should be a six-digit submission tracking number. Information on the STN numbers can be found from the link below.

			Biologics Products & EstablishmentsOr the STN could have been transferred to CDER. A complete listing of STNs transferred to CDER is available from the link below.

			Transfer of Therapeutic Products to CDERBLN not found or not valid
			The Biologics License Number (BLN) transmitted could not be found in the FDA's biologic products database, is not valid, or was declared in an improper format.

			Verify correct AofC code and corresponding qualifier.
			For more information see the list of licensed establishments and applicable products availableFirm name does not match
			The firm name provided in the entry did not match the firm name on file for the AofC transmitted.

			Verify that the firms supplied on the entry match those filed with CBER.
			For more information see Biologics Products & EstablishmentsProduct does not match
			The product transmitted for the entry did not match the corresponding product for the AofC transmitted.

			Verify that the product claimed on the entry matches the product on file with CBER.
			For more information see Biologics Products & EstablishmentsLicensed product status
			The product status for licensed biologic products must be "Approved." The product status of "Approved" was not found for the declared licensed biologic product.

			Verify that the licensed biologic product has been approved.IDE/IND provided/found but did not match
			The product status for investigational biologic products must be "Active" or "Exempt".

			Verify that the IND has the correct status. The IND may also be transferred to the Center for Drug Evaluation and Research
			The investigational biologic product in the line may be transferred to the Center for Devices and Radiological Health (IDE) or the Center for Drug Evaluation and Research (IND).

			For more information see INDs transferred to CDERIDE/IND not found or not valid
			The Investigational New drug (IND) or Investigational Device Exemption (IDE) transmitted could not be found in FDA's biologic products database, is not valid, or was declared in an improper format.

			Verify correct AofC code and corresponding qualifier.IND not intended for biologic products
			The product was declared as a biologic product (Industry code 57), however, the IND declared is insufficient to perform the biologic product lookup.

			Verify the Industry code and/or the AofC declared. If the IND has been transferred to CDER, use a product code that identifies the product as a drug, not a biologic.
			INDs transferred to CDER are available
				Product code builder and tutorialPMA/PMN/NDA/AND not found or not valid
			New Drug Application (NDA), Abbreviated New Drug Application (AND), Premarket Approval (PMA), or Premarket Notification number (510(K)) transmitted could not be found in the FDA's biologic product database, is not valid, or was declared in an improper format.

			Verify correct AofC code and corresponding qualifier.
			For more information see Biologics Products & EstablishmentsPMA/PMN/NDA/AND found but did not match
			New Drug Application (NDA), Abbreviated New Drug Application (AND), Premarket Approval (PMA), or Premarket Notification number (510(K)) transmitted did not match entry data (firm and/or product) transmitted for the entry.

			Verify the firms and product listed on the line match what was submitted for the NDA, ANDA, PMA, or PMN.
			For more information see Biologics Products & EstablishmentsHuman Tissue Registration Number (HRN) Not Found or Not valid
			Human tissue registration number (HRN) transmitted could not be found in the FDA's biologic product database, was not valid, or was declared in an improper format.

			Verify correct AofC code and corresponding qualifier.
			Human Cell and Tissue Establishment Registration Public QueryHRN found but did not match
			Human tissue registration number (HRN) transmitted did not match entry data (firm and/or product) transmitted for the entry.

			Verify the firms and product listed on the line match what was submitted to CBER for the HRN.
			Human Cell and Tissue Establishment Registration Public Query

Back to top

                                                                                  Content current as of:
      10/18/2023Common Entry Submission Errors

          
                        Human Drug Common Entry Errors
          CBER Common Entry Errors
          Medical Device Common Entry Errors
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop